AGFG2 antibody (AA 381-481)
Quick Overview for AGFG2 antibody (AA 381-481) (ABIN872890)
Target
See all AGFG2 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- AA 381-481
-
Cross-Reactivity
- Human, Rat
-
Predicted Reactivity
- Mouse,Cow,Sheep,Pig,Horse,Rabbit
-
Purification
- Purified by Protein A.
-
Immunogen
- KLH conjugated synthetic peptide derived from human AGFG2
-
Isotype
- IgG
-
-
-
-
Application Notes
-
WB 1:300-5000
ELISA 1:500-1000
IHC-P 1:200-400
IHC-F 1:100-500
IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200 -
Restrictions
- For Research Use only
-
-
-
Format
- Liquid
-
Concentration
- 1 μg/μL
-
Buffer
- 0.01M TBS( pH 7.4) with 1 % BSA, 0.02 % Proclin300 and 50 % Glycerol.
-
Preservative
- ProClin
-
Precaution of Use
- This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.
-
Storage
- 4 °C,-20 °C
-
Storage Comment
- Shipped at 4°C. Store at -20°C for one year. Avoid repeated freeze/thaw cycles.
-
Expiry Date
- 12 months
-
-
- AGFG2 (ArfGAP with FG Repeats 2 (AGFG2))
-
Alternative Name
- AGFG2
-
Background
-
Synonyms: Agfg2, AGFG2_HUMAN, Arf GAP domain and FG repeats containing protein 2, Arf-GAP domain and FG repeats-containing protein 2, HIV-1 Rev-binding protein-like protein, HIV1 Rev binding protein like protein, HRBL, Nucleoporin, RAB-R, RABR, Rev/Rex activation domain-binding protein related.
Background: Required for vesicle docking or fusion during acrosome biogenesis (By similarity). May play a role in RNA trafficking or localization. In case of infection by HIV-1, acts as a cofactor for viral Rev and promotes movement of Rev-responsive element-containing RNAs from the nuclear periphery to the cytoplasm. This step is essential for HIV-1 replication.
Target
-